Virtus ETF Advisers LLC Bluebird Bio, Inc. Transaction History

Virtus ETF Advisers LLC

$196 Million
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.91 - $1.75 $15,116 - $29,071	16,612 Added 16.81%	115,461 $147,000
Q4 2023 Feb 15, 2024	BUY	$1.32 - $4.83 $26,429 - $96,706	20,022 Added 25.4%	98,849 $136,000
Q3 2023 Nov 07, 2023	SELL	$3.02 - $4.05 $30,788 - $41,289	-10,195 Reduced 11.45%	78,827 $239,000
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $145,702 - $262,681	52,223 Added 141.91%	89,022 $292,000
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $2,047 - $5,359	652 Added 1.8%	36,799 $117,000
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $208,568 - $306,888	36,147 New	36,147 $250,000
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $119,384 - $212,374	-40,607 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $241,660 - $439,897	26,971 Added 197.79%	40,607 $406,000
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $14,106 - $26,355	-1,255 Reduced 8.43%	13,636 $261,000
Q2 2021 Aug 10, 2021	BUY	$18.04 - $22.09 $147,152 - $180,188	8,157 Added 121.13%	14,891 $476,000
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $1,858 - $3,795	112 Added 1.69%	6,734 $203,000
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $49,775 - $68,635	1,810 Added 37.61%	6,622 $287,000
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $22,937 - $29,137	-666 Reduced 12.16%	4,812 $260,000
Q2 2020 Aug 05, 2020	BUY	$27.12 - $45.97 $39,974 - $67,759	1,474 Added 36.81%	5,478 $334,000
Q1 2020 May 14, 2020	SELL	$26.16 - $63.5 $15,539 - $37,719	-594 Reduced 12.92%	4,004 $184,000
Q4 2019 Feb 13, 2020	BUY	$46.96 - $61.67 $114,770 - $150,721	2,444 Added 113.46%	4,598 $403,000
Q3 2019 Nov 12, 2019	SELL	$59.47 - $93.1 $7,136 - $11,172	-120 Reduced 5.28%	2,154 $198,000
Q2 2019 Aug 13, 2019	SELL	$75.84 - $105.21 $27,378 - $37,980	-361 Reduced 13.7%	2,274 $289,000
Q1 2019 May 14, 2019	SELL	$64.44 - $104.11 $19,267 - $31,128	-299 Reduced 10.19%	2,635 $415,000
Q4 2018 Feb 05, 2019	BUY	$59.1 - $93.26 $30,968 - $48,868	524 Added 21.74%	2,934 $291,000
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $151,950 - $200,907	-1,710 Reduced 41.5%	2,410 $352,000
Q2 2018 Aug 10, 2018	SELL	$99.64 - $127.59 $3,188 - $4,082	-32 Reduced 0.77%	4,120 $647,000
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $234,135 - $334,030	2,213 Added 114.13%	4,152 $709,000
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $81,737 - $131,484	-1,006 Reduced 34.16%	1,939 $345,000
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $15,589 - $24,683	270 Added 10.09%	2,945 $404,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,675	2,675 $281,000

Others Institutions Holding BLUE

# of Institutions

162

Shares Held

79.9M

Call Options Held

525K

Put Options Held

634K

Black Rock Inc. New York, NY

15.4M
Shares

$7.72 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$5.15 Million
0.0% of portfolio
Ameriprise Financial Inc Minneapolis, MN

6.39M
Shares

$3.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.15M
Shares

$2.57 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$2.33 Million
0.02% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $38.6M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account